CN110433232A - 一种外用的复方黄连液及其制备方法 - Google Patents
一种外用的复方黄连液及其制备方法 Download PDFInfo
- Publication number
- CN110433232A CN110433232A CN201910830883.1A CN201910830883A CN110433232A CN 110433232 A CN110433232 A CN 110433232A CN 201910830883 A CN201910830883 A CN 201910830883A CN 110433232 A CN110433232 A CN 110433232A
- Authority
- CN
- China
- Prior art keywords
- parts
- granules
- external application
- huang lian
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 34
- 239000010015 huanglian Substances 0.000 title claims abstract description 33
- 239000008187 granular material Substances 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 20
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229940116229 borneol Drugs 0.000 claims abstract description 20
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 20
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 20
- 244000247747 Coptis groenlandica Species 0.000 claims abstract description 16
- 235000002991 Coptis groenlandica Nutrition 0.000 claims abstract description 16
- 239000009636 Huang Qi Substances 0.000 claims abstract description 16
- 241001113925 Buddleja Species 0.000 claims abstract description 15
- 244000111489 Gardenia augusta Species 0.000 claims abstract description 15
- 235000018958 Gardenia augusta Nutrition 0.000 claims abstract description 15
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 15
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 15
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 14
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 14
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 14
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 14
- 244000197580 Poria cocos Species 0.000 claims abstract description 14
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 14
- 235000008291 Poterium sanguisorba Nutrition 0.000 claims abstract description 14
- 240000004980 Rheum officinale Species 0.000 claims abstract description 14
- 235000008081 Rheum officinale Nutrition 0.000 claims abstract description 14
- 235000008282 Sanguisorba officinalis Nutrition 0.000 claims abstract description 14
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 13
- 240000004064 Poterium sanguisorba Species 0.000 claims abstract description 13
- 244000112814 pipewort Species 0.000 claims abstract description 9
- 239000003814 drug Substances 0.000 claims description 26
- 238000003756 stirring Methods 0.000 claims description 13
- 241000411851 herbal medicine Species 0.000 claims description 11
- 244000025254 Cannabis sativa Species 0.000 claims description 10
- 238000001816 cooling Methods 0.000 claims description 10
- 239000008155 medical solution Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 7
- 230000029087 digestion Effects 0.000 claims description 6
- 239000004744 fabric Substances 0.000 claims description 6
- 238000007654 immersion Methods 0.000 claims description 6
- 230000002708 enhancing effect Effects 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 230000035515 penetration Effects 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 238000005516 engineering process Methods 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 238000002791 soaking Methods 0.000 claims description 3
- 238000004090 dissolution Methods 0.000 claims description 2
- 238000002386 leaching Methods 0.000 claims description 2
- 235000010894 Artemisia argyi Nutrition 0.000 claims 1
- 235000014676 Phragmites communis Nutrition 0.000 claims 1
- 244000030166 artemisia Species 0.000 claims 1
- 238000009835 boiling Methods 0.000 claims 1
- 208000030533 eye disease Diseases 0.000 abstract description 10
- 238000011084 recovery Methods 0.000 abstract description 3
- 210000001508 eye Anatomy 0.000 description 74
- 230000000694 effects Effects 0.000 description 24
- 230000004438 eyesight Effects 0.000 description 13
- 206010052428 Wound Diseases 0.000 description 10
- 208000027418 Wounds and injury Diseases 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 208000002177 Cataract Diseases 0.000 description 7
- 210000000695 crystalline len Anatomy 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 208000010412 Glaucoma Diseases 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 5
- 206010010741 Conjunctivitis Diseases 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 208000001491 myopia Diseases 0.000 description 4
- 238000010025 steaming Methods 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 3
- 208000034699 Vitreous floaters Diseases 0.000 description 3
- 208000034700 Vitreous opacities Diseases 0.000 description 3
- 208000003464 asthenopia Diseases 0.000 description 3
- 201000009310 astigmatism Diseases 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000005252 bulbus oculi Anatomy 0.000 description 3
- 230000001886 ciliary effect Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000004436 pseudomyopia Effects 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010023644 Lacrimation increased Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010034960 Photophobia Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000006196 drop Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000004317 lacrimation Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000004379 myopia Effects 0.000 description 2
- 208000001749 optic atrophy Diseases 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 241000123846 Buddleja officinalis Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241000037740 Coptis chinensis Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 235000002673 Dioscorea communis Nutrition 0.000 description 1
- 241000544230 Dioscorea communis Species 0.000 description 1
- 206010064503 Excessive skin Diseases 0.000 description 1
- 206010052139 Eye oedema Diseases 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 206010052140 Eye pruritus Diseases 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241001113846 Loganiaceae Species 0.000 description 1
- 208000035719 Maculopathy Diseases 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 208000035753 Periorbital contusion Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 229930186706 Puerarin-xyloside Natural products 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 244000173853 Sanguisorba officinalis Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241000543657 Triglochin Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 1
- 239000000571 coke Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 206010023332 keratitis Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- RJKLDOLOCIQYFS-PRTISISMSA-N miroestrol Chemical compound C12=COC3=CC(O)=CC=C3[C@H]2C(C)(C)[C@@H]2[C@@H]([C@H]3O)[C@@]1(O)C(=O)C[C@]3(O)C2 RJKLDOLOCIQYFS-PRTISISMSA-N 0.000 description 1
- CKEZIBBDMDFHQQ-ILKNQKGPSA-N miroestrol Natural products CC1(C)[C@H]2C[C@]3(O)CC(=O)[C@H]([C@@H]2[C@H]3O)C4=COc5ccccc5[C@@H]14 CKEZIBBDMDFHQQ-ILKNQKGPSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 210000001328 optic nerve Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- NAAXIGQVODQJOV-PXYOAQHISA-N puerarin xyloside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C(C1=C(C(C(C=2C=CC(O)=CC=2)=CO1)=O)C=C1)=C1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)CO1 NAAXIGQVODQJOV-PXYOAQHISA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 230000004341 simple myopia Effects 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- 208000005494 xerophthalmia Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/739—Sanguisorba (burnet)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种外用的复方黄连液,其配方包括:黄连27‑60份,黄芪27‑35份,地榆27‑34份,葛根25‑35份,栀子27‑34份,冰片9‑12份,黄芩27‑35份,黄柏25‑35份,大黄24‑34份,茯苓27‑34份,艾叶24‑35份,没药27‑35份,决明子27‑34份,谷精草27‑33份,密蒙花27‑35份。本发明还公开了上述复方黄连液的制备方法。本发明的外用的复方黄连液解决了长期困扰眼睛疾病患者不能彻底根除各种眼睛疾病病痛的问题,其制备方法提取率高。
Description
技术领域
本发明涉及中成药领域,特别涉及一种外用的复方黄连液及其制备方法。
背景技术
当今社会眼睛的各种疾病成为疑难病之一,眼睛成为了最累的器官,工作离不开电脑、沟通离不开手机、娱乐离不开平板,儿童假性近视增多,青少年视力下降、老年人老花眼、黄斑病变、青光眼、角膜炎、白内障等等,眼睛保健成为当今社会影响人们生活的大问题。
眼睛近视、流泪、眼胀眼痒、青光眼、玻璃体浑浊、飞蚊症、白内障是临床常见病之一,它使病人眼睛疲劳、干涩、眼痛看不清事物,严重阻碍了日常工作或学习等,痛苦不堪。目前,西医有滴眼药水和方法对治疗眼睛近视、散光、老花有一定的效果,但是也有不足的地方。
西医治疗眼睛近视的方法只有动手术开刀,通过开刀后削薄眼部晶状体,达到拉近焦距的方法,给眼部患者带来的不只是病痛,还有长期用眼过度后又导致复发,不利于根治。
中医采用中药治疗,使药物活性成分直接穿透眼部皮肤组织及血眼屏障,直达眼底,并通过溶解、雾化、拔浊、润眼四个阶段,高倍强效作用于眼部神经、血管、眼球及病变部位,融治疗、调理、抗菌消炎、滋养四位一体,专业治疗各种眼病。在应用中有一定的预防各种眼睛疾病、矫治视力之功效,但均具有创面愈合慢,时间周期长的缺点。
眼睛近视、缓解假性近视、控制度数增高,调理双眼正常生理功能。去除眼疲劳、眼干涩、眼痛、黑眼圈、眼袋,散光、老花第一症状是眼睛看不清事物,模糊不清,睁开眼睛时看的事物是晃来晃去不稳定,没有固定靶向距离,分不清楚距离的尺寸和远近,时间久了眼睛涨庝难忍。流泪、眼胀眼痒、青光眼、玻璃体浑浊、飞蚊症、白内障,调理双眼恢复正常功能等。眼睛各种病症已经成为当前人们生活、工作和学习迫在眉睫急需解决的问题。
睫状肌长时间的固定在一个点位,紧绷拉升,是导致眼睛近视的根本性的原因。由于眼球晶状体遭到破坏,眼睛焦距被长时间拉长,自己无法自动复原,晶状体和睫状肌的焦距产生了改变,必须把焦距缩短才可以看清楚事物,对于假性单纯的近视,基于每个人的遗传基因、生活环境、个人习惯等都将会导致近视。同时还有每个人长期近距离用眼、较少的户外活动,过多的使用电子产品等都是导致这个原因。
流泪、眼胀、眼痒、散光、老花、结膜炎、青光眼、玻璃体浑浊、飞蚊症、白内障内障等早起炎症是由于眼球血液循环被堵塞,眼部新陈代血管不畅,眼内沉积增加。眼部受损伤组织及眼睛供给各个组织器官发生病变。排除眼内沉积与治眼病发生的致病因子的代谢“垃圾”无法正常排除。同时眼睑的通透性不高,微循环血栓形成,出现内为凝固、中为淤滞、外为充血的现象所致。眼睛有血丝、红肿即结膜炎症状最大的危险是感染。由于创面微血管栓塞,临床通过血液循环输送抗菌素达不到创面部位,眼部自由抗体、自由细胞等免疫物质均不能及时供应创面,因而眼睛充血抗感染效果不理想。因此眼睛炎症的治疗效果要使病员的伤口完全愈合,伤病员最大限度地恢复眼睛的正常的机能,还要恢复眼部视神经系统及各视网膜系统、机能、近视视网膜病变等,同时还要尽量恢复眼睛正常视力。
发明内容
为了克服现有技术的缺点与不足,本发明的目的在于提供一种外用的复方黄连液,能有效综合治疗、深滋养调理,全面修复眼部各种疾病的功能,解决了长期困扰眼睛疾病患者不能彻底根除各种眼睛疾病病痛的问题。
本发明的另一目的在于提供一种外用的复方黄连液的制备方法,中草药有效成分提取高。
本发明的目的通过以下技术方案实现:
一种外用的复方黄连液,其配方包括:
黄连27-60份,黄芪27-35份,地榆27-34份,葛根25-35份,栀子27-34 份,冰片9-12份,黄芩27-35份,黄柏25-35份,大黄24-34份,茯苓27-34 份,艾叶24-35份,没药27-35份,决明子27-34份,谷精草27-33份,密蒙花27-35份。
优选的,所述的外用的复方黄连液,其配方包括:
黄连50,黄芪30,地榆30,葛根30,栀子30,冰片10,黄芩30,黄柏 30,大黄,30,茯苓30,艾叶30,没药30,决明子30,谷精草30,密蒙花30 份。
所述的外用的复方黄连液的制备方法,包括以下步骤:
(1)根据配方称量中草药;
(2)将黄连、黄芪、地榆、葛根、栀子、黄芩、黄柏、大黄、茯苓、艾叶、没药、决明子、谷精草、密蒙花浸泡后混合在一起搅拌均匀;
(3)将浸泡后的中草药进行高温蒸煮:蒸汽煮开后,加热到125-130℃并加压至0.135MPa,得到中草药的有效成分充分浸出的混合药液;
(4)在温度为125℃的条件下,加入冰片作为定向促渗活性因子;
(5)搅拌至冰片溶解后,对混合药液进行冷却后分离,取上清液,过滤后得到外用的复方黄连液。
优选的,步骤(2)所述浸泡为浸泡2-3小时。
优选的,步骤(3)所述高温蒸煮采用高温、高压的医用蒸煮设备,在4个小时内从室温升温至125-130℃。
优选的,步骤(5)所述搅拌,具体为,搅拌10-15分钟。
优选的,步骤(5)所述对混合药液进行冷却后分离,具体为:
优选的,混合液通过冷却塔冷却、提取罐提取、配料罐调配均匀、静置罐静置后分离。
优选的,步骤(5)所述过滤为用800目滤布过滤。
在上述配方的各味中药中:
黄连:《神农本草经百种录》中记载:“黄连,目痛,眦伤泪出,明目,除湿热在上之病。”现代医学研究表明,黄连有清热燥湿,泻火解毒之功效,对于眼睛发炎、发红、发干、发痛和肿胀等症状有奇效,被誉为眼睛的“排毒师”。
黄芪:古名黄耆。明代李时珍在其《本草纲目》中解释说:“耆,长者,黄芪色黄,为补药之长,故名。主要药理作用是“益气固表”,可以“利水”,也可以“托毒生肌”、清火明目、增强免疫功能、促进机体代谢、黄芪富含微量元素硒,硒可以抗癌。具有消除眼部浮肿,激活眼组织细胞,促进新陈代谢。
地榆:始载《神农本草经》,有猪人参、血箭草之称,可以抑制眼睛血管贲张和红血丝,缓解眼部疲劳、肿胀,有“抑菌剂”之称。
葛根:性凉、气平、味甘,具清热、降火、排毒诸功效。葛根中富含多达 13种异黄酮类物质,包括葛根素、葛根素木糖甙、葛雌素,大豆黄酮等,可调理人体机能,增强体质,提高眼睛及机体抗病能力,永保眼睛青春活力。
栀子:栀子的果实是传统中药,具有降压、镇静、止血、消肿、清热。治热病虚烦不眠等作用,帮助眼部疾病的中老年人快速入眠。
冰片:中药名称:右旋龙脑,具有开窍醒神,清热止痛、明目、生肌、抑菌之功效,有效帮助促进药物透过血眼屏障,并具有抗炎镇痛、抗细菌、真菌、病毒,抑制杀灭有害微生物的作用。
黄芩:功能:清热燥湿、消炎抗菌、消肿,具有清热燥湿,泻火清心、凉血活血的功效,对人体的作用功效多种多样:1、抗菌、抗病毒:黄芩对革兰氏阳性菌、革兰氏阴性菌、致病性皮肤真菌都有一定抑制作用。
黄柏:主要功效和作用为清热燥湿、泻火除蒸、解毒疗疮。促进眼睛皮下组织淤血的吸收。
大黄:功效:泻下攻积、清热泻火、凉血解毒、逐瘀通经。能够消肿利水, 活血化瘀.含有大黄酚,可分解眼部血液在毛细血管的扩张。
茯苓:具有利水消肿,渗湿,宁心的功效.主治水肿,脾虚泄泻,心悸,失眠。有利于眼睛快速入眠。
艾叶:龙脑、干燥叶。辛、苦、温、有小毒、归肝脾肾经,功效:温经止血、祛湿止痒,散寒。主治症:出血症、可以抑制眼睛血管出血。
没药:苦、平;功能主治:活血止痛,消肿生肌,跌打损伤,痈肿疮疡,目赤肿痛。眼部外伤止痛,消肿的作用。
决明子:〈〈本经〉〉:“主青盲,目淫肤赤白膜,眼赤痛,泪出。久服益精光。治疗一些目赤涩痛,眼睛多泪,头痛眩晕,眼睛视物不清。
谷精草:具有疏散风热,明目,退翳功效。主治风热目赤,眼生翳膜。特别对于眼睛的疾病有很好的效果。风热之邪而引起的眼睛发红、灼热、眼屎过多、流泪、眼睛干涩,都可以进行治疗。
密蒙花:中药名为马钱科植物密蒙花BuddlejaofficinalisMaxim.的干燥花蕾。具有清热泻火,养肝明目,退翳功效。主治目赤肿痛,羞明多泪,眼生翳膜, 肝虚目暗,视物昏花模糊不清。功效作用:明目治目赤肿痛、多泪羞明、青盲翳障、风弦烂眼清肝明目。眼科专用药、用于血虚肝热之眼病作用。
与现有技术相比,本发明具有以下优点和有益效果:
(1)本发明的外用的复方黄连液,是一种护眼的复方爱眼液,适用于眼睛及表面皮肤上,可治疗长期过度用眼引起的慢性视疲劳、干眼症、慢性病所致眼底病变、青少年近视、老年人早期白内障。急性结膜炎、充血性结膜炎、出血性眼病以及青光眼等。它具有清热解毒、消肿止痛、眼睛发红、灼热、眼屎过多、流泪、眼睛干涩,有效控制及防止感染、缓解睫状肌、加速创面愈合、疗效迅速、价格低廉。能有效综合治疗、深滋养调理,全面修复眼部各种疾病的功能。本发明解决了长期困扰眼睛疾病患者不能彻底根除各种眼睛疾病病痛的问题。
(2)本发明的外用的复方黄连液的制备方法,通过加温到125℃,水中细菌被全部杀死,通过通过高温高压使每款药材的有效成分充分浸出,提取率高。
具体实施方式
下面结合实施例,对本发明作进一步地详细说明,但本发明的实施方式不限于此。
实施例1
本实施例的外用的复方黄连液,其配方为:
黄连60g,黄芪30g,地榆30g,葛根30g,栀子30g,冰片10g,黄芩30g,黄柏30g,大黄30g,茯苓30g,艾叶30g,没药30g,决明子30g,谷精草30g,密蒙花30g。
本实施例的外用的复方黄连液的制备方法如下:
(1)根据配方称量中草药;
(2)将黄连、黄芪、地榆、葛根、栀子、黄芩、黄柏、大黄、茯苓、艾叶、没药、决明子、谷精草、密蒙花加水3L浸泡2小时后混合在一起搅拌均匀;
(3)将浸泡后的中草药进行高温蒸煮:蒸汽煮开后,加热到125℃并加压至0.135MPa,得到中草药的有效成分充分浸出的混合药液;本实施例采用高温、高压的医用蒸煮设备,在4个小时内从室温升温至125℃;
(4)在温度为125℃的条件下,加入冰片作为定向促渗活性因子;
(5)搅拌10分钟至冰片溶解后,混合液通过冷却塔采用循环水低温冷却技术进行冷却,经提取罐提取、配料罐调配均匀、静置罐静置后分离,取上清液,用800目滤布过滤后得到外用的复方黄连液。
本实施例的外用的复方黄连液试用报告:
使用方法:于眼睛创面或眼睛晶状体上,用纱布浸湿直接敷于眼睛表面,每日2-3次。
试用志愿者,女,13岁,中学生。调整前视力左眼为:0.2度,右眼为: 0.2度。小孩戴个度数很高的近视镜,坐在教室的后排眼睛难受还是基本看不清黑板上的字。用了本发明药物3个月后,调整后视力左眼为:1.2度,右眼为: 1.2度。上课看黑板很快看的清楚。晚上睡觉时用效果更佳,每天敷30分钟。
严重患者每日三次用发明药物,3个月后,一般150度左右假性近视患者可以把度数降下来变为正常的视力。
实施例2
本实施例的外用的复方黄连液,其配方为:
黄连35g,黄芪30g,地榆30g,葛根30g,栀子30g,冰片8g,黄芩30g,黄柏30g,大黄30g,茯苓30g,艾叶33g,没药28g,决明子35g,谷精草35g,密蒙花35g。
本实施例的外用的复方黄连液的制备方法如下:
(1)根据配方称量中草药;
(2)将黄连、黄芪、地榆、葛根、栀子、黄芩、黄柏、大黄、茯苓、艾叶、没药、决明子、谷精草、密蒙花加水3L浸泡2小时后混合在一起搅拌均匀;
(3)将浸泡后的中草药进行高温蒸煮:蒸汽煮开后,加热到130℃并加压至0.140MPa,得到中草药的有效成分充分浸出的混合药液;本实施例采用高温、高压的医用蒸煮设备,在4个小时内从室温升温至130℃;
(4)在温度为130℃的条件下,加入冰片作为定向促渗活性因子;
(5)搅拌10分钟至冰片溶解后,混合液通过冷却塔采用循环水低温冷却技术进行冷却,经提取罐提取、配料罐调配均匀、静置罐静置后分离,取上清液,用800目滤布过滤后得到外用的复方黄连液。
本实施例的外用的复方黄连液试用报告:
使用方法:于眼睛创面或眼睛晶状体上,用纱布浸湿直接敷于眼睛表面,每日2-3次。
试用志愿者,女,52岁,村民。眼睛发痒,模糊,流眼泪,还有老花。感觉眼睛经常干涩睁不开,眼睛经常模糊和流眼泪晚上也休息不好。滴于本药水在眼睛创面,并且者用无纺布浸湿后直接敷于眼睛表面,每天敷40分钟,用了本发明药物60天后以上症状基本痊愈。
实施例3
黄连27g,黄芪27g,地榆27g,葛根25g,栀子27g,冰片9g,黄芩27g,黄柏25g,大黄24g,茯苓27g,艾叶24g,没药27g,决明子27g,谷精草27-33g,密蒙花27g。
本实施例的外用的复方黄连液的制备方法如下:
(1)根据配方称量中草药;
(2)将黄连、黄芪、地榆、葛根、栀子、黄芩、黄柏、大黄、茯苓、艾叶、没药、决明子、谷精草、密蒙花加水3L浸泡2小时后混合在一起搅拌均匀;
(3)将浸泡后的中草药进行高温蒸煮:蒸汽煮开后,加热到125~130℃并加压至0.135MPa,得到中草药的有效成分充分浸出的混合药液;本实施例采用高温、高压的医用蒸煮设备,在4个小时内从室温升温至125~130℃;
(4)在温度为125℃的条件下,加入冰片作为定向促渗活性因子;
(5)搅拌15分钟至冰片溶解后,混合液通过冷却塔采用循环水低温冷却技术进行冷却,经提取罐提取、配料罐调配均匀、静置罐静置后分离,取上清液,用800目滤布过滤后得到外用的复方黄连液。
使用方法:于眼睛创面或眼睛晶状体上,用纱布浸湿直接敷于眼睛表面,每日2-3次。
试用志愿者,女,72岁,退休工人。属于白内障早期患者,眼睛平时看远处模糊,一睁眼就流眼泪。眼球上有白色的斑块,每天痛苦不堪。在用了本药水在眼睛创面上,并且用无纺布浸湿后直接敷于眼睛表面上,每天敷40分钟。 90天后,模糊和流泪症状基本上消失;眼球晶状体白色的异物也逐渐淡化,散瘀;视觉基本恢复,斑块也逐步淡化痊愈。
上述实施例为本发明较佳的实施方式,但本发明的实施方式并不受所述实施例的限制,其他的任何未背离本发明的精神实质与原理下所作的改变、修饰、替代、组合、简化,均应为等效的置换方式,都包含在本发明的保护范围之内。
Claims (9)
1.一种外用的复方黄连液,其特征在于,其配方包括:
黄连27-60份,黄芪27-35份,地榆27-34份,葛根25-35份,栀子27-34份,冰片9-12份,黄芩27-35份,黄柏25-35份,大黄24-34份,茯苓27-34份,艾叶24-35份,没药27-35份,决明子27-34份,谷精草27-33份,密蒙花27-35份。
2.根据权利要求1所述的外用的复方黄连液,其特征在于,其配方包括:
黄连50,黄芪30,地榆30,葛根30,栀子30,冰片10,黄芩30,黄柏30,大黄,30,茯苓30,艾叶30,没药30,决明子30,谷精草30,密蒙花30份。
3.根据权利要求1或2所述的外用的复方黄连液的制备方法,其特征在于,包括以下步骤:
(1)根据配方称量中草药;
(2)将黄连、黄芪、地榆、葛根、栀子、黄芩、黄柏、大黄、茯苓、艾叶、没药、决明子、谷精草、密蒙花加水浸泡后混合在一起搅拌均匀;
(3)将浸泡后的中草药进行高温蒸煮:蒸汽煮开后,加热到125-130℃并加压至0.135-0.140MPa,得到中草药的有效成分充分浸出的混合药液;
(4)在温度为125-130℃的条件下,加入冰片作为定向促渗活性因子;
(5)搅拌至冰片溶解后,对混合药液进行冷却后分离,取上清液,过滤后得到外用的复方黄连液。
4.根据权利要求3所述的外用的复方黄连液的制备方法,其特征在于,步骤(2)所述浸泡为浸泡2-3小时。
5.根据权利要求3所述的外用的复方黄连液的制备方法,其特征在于,步骤(3)所述高温蒸煮采用高温、高压的医用蒸煮设备,在4个小时内从室温升温至125-130℃。
6.根据权利要求3所述的外用的复方黄连液的制备方法,其特征在于,步骤(5)所述搅拌,具体为,搅拌10-15分钟。
7.根据权利要求3所述的外用的复方黄连液的制备方法,其特征在于,步骤(5)所述对混合药液进行冷却后分离,具体为:
混合液通过冷却塔冷却、提取罐提取、配料罐调配均匀、静置罐静置后分离。
8.根据权利要求3所述的外用的复方黄连液的制备方法,其特征在于,步骤(5)所述过滤为用800目滤布过滤。
9.根据权利要求3或7所述的外用的复方黄连液的制备方法,其特征在于,步骤(5)所述冷却为采用循环水低温冷却技术进行冷却。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910830883.1A CN110433232A (zh) | 2019-09-03 | 2019-09-03 | 一种外用的复方黄连液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910830883.1A CN110433232A (zh) | 2019-09-03 | 2019-09-03 | 一种外用的复方黄连液及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110433232A true CN110433232A (zh) | 2019-11-12 |
Family
ID=68439079
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910830883.1A Pending CN110433232A (zh) | 2019-09-03 | 2019-09-03 | 一种外用的复方黄连液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110433232A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113018337A (zh) * | 2021-01-08 | 2021-06-25 | 深圳好健康生物制药有限公司 | 一种治疗眼疾的复方及其制备方法与应用 |
EP4164640A4 (en) * | 2020-06-11 | 2024-07-17 | Univ Columbia | METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING MYOPIA WITH BERBERINE, A BERBERIDACEOUS ALKALOID, AND DERIVATIVES THEREOF |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105770416A (zh) * | 2016-03-22 | 2016-07-20 | 广州暨南生物医药研究开发基地有限公司 | 一种含艾叶的治疗眼目暴赤肿痛的中药制剂及其制备方法 |
CN109865016A (zh) * | 2019-03-28 | 2019-06-11 | 成都中医药大学 | 一种治疗干眼症的药物组合物及其制备方法和用途 |
CN109876050A (zh) * | 2019-04-24 | 2019-06-14 | 深圳市康视力生物科技有限公司 | 复方黄芪液 |
-
2019
- 2019-09-03 CN CN201910830883.1A patent/CN110433232A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105770416A (zh) * | 2016-03-22 | 2016-07-20 | 广州暨南生物医药研究开发基地有限公司 | 一种含艾叶的治疗眼目暴赤肿痛的中药制剂及其制备方法 |
CN109865016A (zh) * | 2019-03-28 | 2019-06-11 | 成都中医药大学 | 一种治疗干眼症的药物组合物及其制备方法和用途 |
CN109876050A (zh) * | 2019-04-24 | 2019-06-14 | 深圳市康视力生物科技有限公司 | 复方黄芪液 |
Non-Patent Citations (2)
Title |
---|
妮妮: "眼睛不舒服就用利安正-天然草本护眼贴(内附视频)", 《百度》 * |
庞雅菊等: "中药洗一号治疗眼部接触性皮炎的临床观察", 《中国中医眼科杂志》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4164640A4 (en) * | 2020-06-11 | 2024-07-17 | Univ Columbia | METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING MYOPIA WITH BERBERINE, A BERBERIDACEOUS ALKALOID, AND DERIVATIVES THEREOF |
CN113018337A (zh) * | 2021-01-08 | 2021-06-25 | 深圳好健康生物制药有限公司 | 一种治疗眼疾的复方及其制备方法与应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102631558B (zh) | 一种用于治疗眼疾的中成药及其制备方法 | |
CN102319372A (zh) | 一种治疗心经郁热型褥疮的中药洗剂制备方法 | |
CN106901896A (zh) | 一种排毒保健眼罩 | |
CN102327517B (zh) | 一种治疗风火型褥疮的中药洗剂制备方法 | |
CN110433232A (zh) | 一种外用的复方黄连液及其制备方法 | |
CN102631557B (zh) | 治疗白内障、外障、老花眼和近视中药组合物及制备方法 | |
CN102327443A (zh) | 一种治疗搔痒型褥疮的中药洗剂制备方法 | |
CN108114084A (zh) | 一种用于提高视力的中药组合物及其制备方法 | |
CN102327442B (zh) | 一种治疗不寐型褥疮的中药洗剂制备方法 | |
CN107929670A (zh) | 一种治疗视力模糊的药物眼罩及其制备方法 | |
CN102198227A (zh) | 一种治疗阴虚型青光眼的中药制备方法 | |
CN102755549B (zh) | 一种治疗白内障的药物及其制备方法 | |
CN105998755A (zh) | 治疗近视弱视用温灸药物及温灸装置 | |
CN106362089A (zh) | 一种治疗眼科疾病的外用药物 | |
CN104523981A (zh) | 一种治疗视神经炎的中药制剂及制备方法 | |
CN1162454A (zh) | 一种翠竹熏眼液及其配制方法 | |
CN109223919A (zh) | 一种石墨烯瑶药护眼罩及其制备方法 | |
CN104644747A (zh) | 一种主要用于治疗假性近视的敷眼液 | |
CN102579724B (zh) | 一种治疗青光眼的中药组合物 | |
CN107875297A (zh) | 一种治疗眩晕症的中药组合物及其制备方法 | |
CN113893087B (zh) | 调理近视、弱视、散光及视疲劳的中药眼罩及制作方法 | |
CN107582771A (zh) | 贴敷眼睑缓解视疲劳的贴敷制剂及其制备方法 | |
CN105148118B (zh) | 一种治疗干眼症的中药组合物药剂及其制备方法 | |
CN106309779A (zh) | 具有舒缓视疲劳的眼药水及其制备方法 | |
CN106729402A (zh) | 一种治疗脑萎的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191112 |